List of differential plasma proteins compared with control malaria-infected
Symbol . | Protein name . | Fold change (log2) HGB drop with SMA . | P value HGB drop with SMA . | Fold change (log2) HGB drop without SMA . | P value HGB drop without SMA . |
---|---|---|---|---|---|
AHCY | Adenosylhomocysteinase | 0.35 | .04 | 1.18 | .06 |
AK1 | Adenylate kinase 1 | −0.53 | .03 | −0.13 | .5 |
ALPL | Alkaline phosphatase, liver/bone/kidney | −0.60 | .03 | −0.30 | .2 |
AMBP | α-1-microglobulin | −0.35 | .3 | −0.66 | .04 |
ANGPTL6 | Angiopoietin-like 6 | −0.55 | .04 | 0.07 | .7 |
ANPEP | Alanyl (membrane) aminopeptidase | −0.50 | .05 | −0.63 | .04 |
ATF6 | Activating transcription factor 6 | 0.30 | .2 | 0.52 | .04 |
ATRN | Attractin | −1.02 | .01 | −0.78 | .04 |
BPGM | 2,3-bisphosphoglycerate mutase | 0.22 | .5 | 1.25 | .04 |
C4BPA | Complement component 4 binding protein, α | −2.08 | .02 | −1.81 | .1 |
C4BPB | Complement component 4 binding protein, β | −1.36 | .03 | −0.93 | .2 |
C8A | Complement component 8, α polypeptide | −0.45 | .01 | −0.36 | .1 |
C8G | Complement component 8, γ polypeptide | −0.51 | .03 | −0.54 | .02 |
CADM1 | Cell adhesion molecule 1 | −0.52 | .1 | −0.74 | .04 |
CD59 | CD59 molecule, complement regulatory protein | 0.42 | .046 | 0.36 | .2 |
CD84 | CD84 molecule | −0.24 | .4 | −0.35 | .02 |
CR2 | Complement component (3d/Epstein Barr virus) receptor 2 | −1.23 | .03 | −0.71 | .1 |
CRISP3 | Cysteine-rich secretory protein 3 | −0.50 | .1 | −0.57 | .001 |
ECM1 | Extracellular matrix protein 1 | −0.29 | .02 | −0.21 | .1 |
ENO2 | Enolase 2 (γ, neuronal) | −0.80 | .04 | −0.29 | .5 |
FAT1 | FAT atypical cadherin 1 | −0.20 | .03 | 0.10 | .2 |
FGFBP2 | Fibroblast growth factor binding protein 2 | 0.45 | .3 | 1.03 | .03 |
GCLC | Glutamate-cysteine ligase, catalytic subunit | −0.11 | .6 | 0.78 | .04 |
HABP2 | Hyaluronan binding protein 2 | 0.56 | .03 | 0.19 | .4 |
HNRNPA2B1 | Heterogeneous nuclear ribonucleoprotein A2/B1 | 0.38 | .07 | 0.53 | .02 |
HPX | Hemopexin | −0.47 | .07 | −0.59 | .01 |
ICOSLG | Inducible T-cell co-stimulator ligand | −0.63 | .002 | −0.44 | .004 |
IGFALS | Insulin-like growth factor binding protein, acid labile subunit | −1.45 | .01 | −1.45 | .07 |
IGFBP1 | Insulin-like growth factor binding protein 1 | 1.05 | .2 | 1.70 | .02 |
IGFBP3 | Insulin-like growth factor binding protein 3 | −0.91 | .06 | −0.95 | .01 |
IGKC | Immunoglobulin κ constant | −1.26 | .04 | −1.06 | .07 |
IL6ST | Interleukin 6 signal transducer | −0.40 | .3 | −0.42 | .01 |
KLKB1 | Kallikrein B, plasma (Fletcher factor) 1 | −0.94 | .004 | −0.89 | .01 |
LIPG | Lipase, endothelial | −0.18 | .2 | −0.33 | .02 |
LMAN2 | Lectin, mannose-binding 2 | 0.40 | .001 | 0.16 | .5 |
MBL2 | Mannose-binding lectin (protein C) 2, soluble | −1.42 | .2 | −1.99 | .03 |
MELTF | Melanotransferrin OS=Homo sapiens GN=MFI2 PE=1 SV=2 | 0.20 | .02 | 0.11 | .5 |
MFI2 | antigen p97 | 0.20 | .02 | 0.11 | .5 |
NAMPT | Nicotinamide phosphoribosyltransferase | 0.57 | .046 | 1.09 | .1 |
NBL1 | Neuroblastoma 1, DAN family BMP antagonist | −0.34 | .4 | −0.37 | .02 |
NCAM1 | Neural cell adhesion molecule 1 | −0.19 | .6 | −0.48 | .03 |
PLS3 | Plastin 3 | −0.99 | .02 | −0.34 | .3 |
PLTP | Phospholipid transfer protein | 0.45 | .02 | 0.58 | .03 |
PON3 | Paraoxonase 3 | −1.01 | .04 | 0.05 | .9 |
PRAP1 | Proline-rich acidic protein 1 | 1.06 | .046 | 0.99 | .01 |
PROCR | Protein C receptor, endothelial | −0.80 | .04 | −0.70 | .2 |
PRSS3P2 | Putative trypsin-6 | −0.37 | .04 | −0.22 | .5 |
PSMA1 | Proteasome subunit α 1 | 0.43 | .02 | 0.83 | .047 |
PSMA2 | Proteasome subunit α 2 | 0.50 | .02 | 1.05 | .03 |
PSMA4 | Proteasome subunit α 4 | 0.39 | .03 | 0.86 | .03 |
PSMA6 | Proteasome subunit α 6 | 0.46 | .02 | 0.99 | .05 |
PSMA7 | Proteasome subunit α 7 | 0.34 | .01 | 0.77 | .07 |
PSMB1 | Proteasome subunit β 1 | 0.31 | .1 | 0.74 | .02 |
PSMB10 | Proteasome subunit β 10 | 0.74 | .03 | 0.87 | .03 |
PSMB3 | Proteasome subunit β 3 | 0.51 | .05 | 1.05 | .02 |
PSMB4 | Proteasome subunit β 4 | 0.42 | .005 | 1.00 | .04 |
PSMB5 | Proteasome subunit β 5 | 0.26 | .4 | 1.06 | .01 |
PSMB6 | Proteasome subunit β 6 | 0.36 | .5 | 1.20 | .04 |
PZP | Pregnancy-zone protein | −1.67 | .04 | −1.65 | .02 |
SERPINA7 | Serpin peptidase inhibitor, clade A | −0.43 | .03 | −0.58 | .02 |
TGFBI | Transforming growth factor, β-induced, 68kDa | 0.62 | .2 | 0.39 | .02 |
TNFAIP6 | Tumor necrosis factor, α-induced protein 6 | −0.41 | .01 | −0.01 | 1.0 |
ZYX | Zyxin | −0.35 | .2 | −0.61 | .04 |
Symbol . | Protein name . | Fold change (log2) HGB drop with SMA . | P value HGB drop with SMA . | Fold change (log2) HGB drop without SMA . | P value HGB drop without SMA . |
---|---|---|---|---|---|
AHCY | Adenosylhomocysteinase | 0.35 | .04 | 1.18 | .06 |
AK1 | Adenylate kinase 1 | −0.53 | .03 | −0.13 | .5 |
ALPL | Alkaline phosphatase, liver/bone/kidney | −0.60 | .03 | −0.30 | .2 |
AMBP | α-1-microglobulin | −0.35 | .3 | −0.66 | .04 |
ANGPTL6 | Angiopoietin-like 6 | −0.55 | .04 | 0.07 | .7 |
ANPEP | Alanyl (membrane) aminopeptidase | −0.50 | .05 | −0.63 | .04 |
ATF6 | Activating transcription factor 6 | 0.30 | .2 | 0.52 | .04 |
ATRN | Attractin | −1.02 | .01 | −0.78 | .04 |
BPGM | 2,3-bisphosphoglycerate mutase | 0.22 | .5 | 1.25 | .04 |
C4BPA | Complement component 4 binding protein, α | −2.08 | .02 | −1.81 | .1 |
C4BPB | Complement component 4 binding protein, β | −1.36 | .03 | −0.93 | .2 |
C8A | Complement component 8, α polypeptide | −0.45 | .01 | −0.36 | .1 |
C8G | Complement component 8, γ polypeptide | −0.51 | .03 | −0.54 | .02 |
CADM1 | Cell adhesion molecule 1 | −0.52 | .1 | −0.74 | .04 |
CD59 | CD59 molecule, complement regulatory protein | 0.42 | .046 | 0.36 | .2 |
CD84 | CD84 molecule | −0.24 | .4 | −0.35 | .02 |
CR2 | Complement component (3d/Epstein Barr virus) receptor 2 | −1.23 | .03 | −0.71 | .1 |
CRISP3 | Cysteine-rich secretory protein 3 | −0.50 | .1 | −0.57 | .001 |
ECM1 | Extracellular matrix protein 1 | −0.29 | .02 | −0.21 | .1 |
ENO2 | Enolase 2 (γ, neuronal) | −0.80 | .04 | −0.29 | .5 |
FAT1 | FAT atypical cadherin 1 | −0.20 | .03 | 0.10 | .2 |
FGFBP2 | Fibroblast growth factor binding protein 2 | 0.45 | .3 | 1.03 | .03 |
GCLC | Glutamate-cysteine ligase, catalytic subunit | −0.11 | .6 | 0.78 | .04 |
HABP2 | Hyaluronan binding protein 2 | 0.56 | .03 | 0.19 | .4 |
HNRNPA2B1 | Heterogeneous nuclear ribonucleoprotein A2/B1 | 0.38 | .07 | 0.53 | .02 |
HPX | Hemopexin | −0.47 | .07 | −0.59 | .01 |
ICOSLG | Inducible T-cell co-stimulator ligand | −0.63 | .002 | −0.44 | .004 |
IGFALS | Insulin-like growth factor binding protein, acid labile subunit | −1.45 | .01 | −1.45 | .07 |
IGFBP1 | Insulin-like growth factor binding protein 1 | 1.05 | .2 | 1.70 | .02 |
IGFBP3 | Insulin-like growth factor binding protein 3 | −0.91 | .06 | −0.95 | .01 |
IGKC | Immunoglobulin κ constant | −1.26 | .04 | −1.06 | .07 |
IL6ST | Interleukin 6 signal transducer | −0.40 | .3 | −0.42 | .01 |
KLKB1 | Kallikrein B, plasma (Fletcher factor) 1 | −0.94 | .004 | −0.89 | .01 |
LIPG | Lipase, endothelial | −0.18 | .2 | −0.33 | .02 |
LMAN2 | Lectin, mannose-binding 2 | 0.40 | .001 | 0.16 | .5 |
MBL2 | Mannose-binding lectin (protein C) 2, soluble | −1.42 | .2 | −1.99 | .03 |
MELTF | Melanotransferrin OS=Homo sapiens GN=MFI2 PE=1 SV=2 | 0.20 | .02 | 0.11 | .5 |
MFI2 | antigen p97 | 0.20 | .02 | 0.11 | .5 |
NAMPT | Nicotinamide phosphoribosyltransferase | 0.57 | .046 | 1.09 | .1 |
NBL1 | Neuroblastoma 1, DAN family BMP antagonist | −0.34 | .4 | −0.37 | .02 |
NCAM1 | Neural cell adhesion molecule 1 | −0.19 | .6 | −0.48 | .03 |
PLS3 | Plastin 3 | −0.99 | .02 | −0.34 | .3 |
PLTP | Phospholipid transfer protein | 0.45 | .02 | 0.58 | .03 |
PON3 | Paraoxonase 3 | −1.01 | .04 | 0.05 | .9 |
PRAP1 | Proline-rich acidic protein 1 | 1.06 | .046 | 0.99 | .01 |
PROCR | Protein C receptor, endothelial | −0.80 | .04 | −0.70 | .2 |
PRSS3P2 | Putative trypsin-6 | −0.37 | .04 | −0.22 | .5 |
PSMA1 | Proteasome subunit α 1 | 0.43 | .02 | 0.83 | .047 |
PSMA2 | Proteasome subunit α 2 | 0.50 | .02 | 1.05 | .03 |
PSMA4 | Proteasome subunit α 4 | 0.39 | .03 | 0.86 | .03 |
PSMA6 | Proteasome subunit α 6 | 0.46 | .02 | 0.99 | .05 |
PSMA7 | Proteasome subunit α 7 | 0.34 | .01 | 0.77 | .07 |
PSMB1 | Proteasome subunit β 1 | 0.31 | .1 | 0.74 | .02 |
PSMB10 | Proteasome subunit β 10 | 0.74 | .03 | 0.87 | .03 |
PSMB3 | Proteasome subunit β 3 | 0.51 | .05 | 1.05 | .02 |
PSMB4 | Proteasome subunit β 4 | 0.42 | .005 | 1.00 | .04 |
PSMB5 | Proteasome subunit β 5 | 0.26 | .4 | 1.06 | .01 |
PSMB6 | Proteasome subunit β 6 | 0.36 | .5 | 1.20 | .04 |
PZP | Pregnancy-zone protein | −1.67 | .04 | −1.65 | .02 |
SERPINA7 | Serpin peptidase inhibitor, clade A | −0.43 | .03 | −0.58 | .02 |
TGFBI | Transforming growth factor, β-induced, 68kDa | 0.62 | .2 | 0.39 | .02 |
TNFAIP6 | Tumor necrosis factor, α-induced protein 6 | −0.41 | .01 | −0.01 | 1.0 |
ZYX | Zyxin | −0.35 | .2 | −0.61 | .04 |
HGB, hemoglobin. P values <0.05 are bolded, and P values 0.05-0.09 are italicized.